<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss version="2.0">
  <channel>
    <title>MabThera RSS News</title>
    <description>MabThera.com is a comprehensive resource for healthcare professionals outside the US who are interested in MabThera and the treatment of lymphomas.</description>
    <language>en</language>
    <link>http://www.mabthera.com</link>
    <image>
      <title>rssfeed</title>
      <url>http://www.mabthera.com/portal/servlet/service/servicePicture?serviceId=15300036&amp;pictureName=rssfeed</url>
      <link>http://www.mabthera.com</link>
    </image>
    <pubDate>Thu, 09 Apr 2009 00:00:00 CEST</pubDate>
    <managingEditor>welcome@mabthera.com</managingEditor>
    <webmaster>welcome@mabthera.com</webmaster>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/Mabthera" type="application/rss+xml" /><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.feedburner.com%2FMabthera" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.feedburner.com%2FMabthera" src="http://www.netvibes.com/img/add2netvibes.gif">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2FMabthera" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><item>
      <title>Presenting signs and symptoms of CLL</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/presenting_signs_and_symptoms_of_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/THiMI5YWdk8" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/presenting_signs_and_symptoms_of_cll</url>
      </source>
    </item>
    <item>
      <title>Disease background</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/disease_background_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/ZfqsAkywCNw" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/disease_background_cll</url>
      </source>
    </item>
    <item>
      <title>Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/news</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/7h2E17X4DTk" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 21 May 2007 00:00:00 CEST</pubDate>
      <author>training</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/news</url>
      </source>
    </item>
    <item>
      <title>Treating CLL</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/treating_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/fyKmM7v_I4E" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/treating_cll</url>
      </source>
    </item>
    <item>
      <title>Stages</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/about_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/ZkkkSOnWE_U" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 14 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/about_cll</url>
      </source>
    </item>
    <item>
      <title>Brief prescribing information</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/mabthera_is_well_tolerated_in_first-line_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/M1v2JFnhwnE" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 10:26:27 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/mabthera_is_well_tolerated_in_first-line_cll</url>
      </source>
    </item>
    <item>
      <title>Disclaimer</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/active_ingredient</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/OgrXiaW_FIY" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 22 Apr 2009 18:46:43 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/active_ingredient</url>
      </source>
    </item>
    <item>
      <title>About NHL</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/nhl</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/Rob7x5Mpaz8" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 14 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/nhl</url>
      </source>
    </item>
    <item>
      <title>MabThera maintenance therapy</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/stages_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/QiGRQf6DiZQ" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 17:00:48 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/stages_cll</url>
      </source>
    </item>
    <item>
      <title>Possible factors that may contribute to CLL development</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/possible_factors_that_may_contribute_to_cll_development</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/L-arL4aJic4" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 15:49:17 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/possible_factors_that_may_contribute_to_cll_development</url>
      </source>
    </item>
    <item>
      <title>Prognostic factors</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/about_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/ZkkkSOnWE_U" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 14 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/about_cll</url>
      </source>
    </item>
    <item>
      <title>MabThera is well tolerated in first-line CLL</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/treating_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/fyKmM7v_I4E" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/treating_cll</url>
      </source>
    </item>
    <item>
      <title>MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alonea</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/news</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/7h2E17X4DTk" height="1" width="1"/&gt;</description>
      <pubDate>Sun, 03 Jun 2007 00:00:00 CEST</pubDate>
      <author>training</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/news</url>
      </source>
    </item>
    <item>
      <title>Treating CLL</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/nHdxXsWVYV8" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 14 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/cll</url>
      </source>
    </item>
    <item>
      <title>Prognostic factors</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/prognostic_factors_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/43WwvGWKzZc" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/prognostic_factors_cll</url>
      </source>
    </item>
    <item>
      <title>About CLL</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/about_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/ZkkkSOnWE_U" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 08 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/about_cll</url>
      </source>
    </item>
    <item>
      <title>Disclaimer</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/home</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/e9Mh98-OnSo" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 06 May 2009 00:00:00 CEST</pubDate>
      <author>admin</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/home</url>
      </source>
    </item>
    <item>
      <title>Brief prescribing information</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/treating_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/fyKmM7v_I4E" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 10:21:16 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/treating_cll</url>
      </source>
    </item>
    <item>
      <title>MabThera provides the longest time free from the burden of CLL</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/treating_cll</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/fyKmM7v_I4E" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 Apr 2009 00:00:00 CEST</pubDate>
      <author>mabthera_team</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/treating_cll</url>
      </source>
    </item>
    <item>
      <title>MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen</title>
      <link>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/news</link>
      <description>&lt;img src="http://feeds.feedburner.com/~r/Mabthera/~4/7h2E17X4DTk" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 02 May 2007 00:00:00 CEST</pubDate>
      <author>training</author>
      <source>
        <title>MabThera RSS News</title>
        <url>http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera/news</url>
      </source>
    </item>
  </channel>
</rss>
